NOTV Key Statistics, Chart & Performance
The current stock price of NOTV is 0.6074 USD. In the past month the price decreased by -27.81%. In the past year, price decreased by -86.1%.
NOTV Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 27.63 | 232.51B | ||
| DHR | DANAHER CORP | 30.92 | 168.37B | ||
| BRKRP | BRUKER CORP - BRKR 6 3/8 09/01/28 | 200.78 | 61.01B | ||
| A | AGILENT TECHNOLOGIES INC | 26.62 | 42.11B | ||
| IQV | IQVIA HOLDINGS INC | 20.84 | 41.28B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 35.5 | 30.34B | ||
| WAT | WATERS CORP | 31.24 | 23.62B | ||
| ILMN | ILLUMINA INC | 32.36 | 21.56B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 38.97 | 19.82B | ||
| MEDP | MEDPACE HOLDINGS INC | 41.61 | 16.76B | ||
| RVTY | REVVITY INC | 21.8 | 11.84B | ||
| TEM | TEMPUS AI INC | N/A | 11.79B |
Related stock screener links
About NOTV
Company Profile
Inotiv, Inc. is a pharmaceutical development company, which engages in the provision of nonclinical and analytical drug discovery and development services primarily to the pharmaceutical and medical device industries and selling a range of research-quality animals and diets to academia and government clients. The company is headquartered in West Lafayette, Indiana and currently employs 1,945 full-time employees. Its products and services focus on bringing new drugs and medical devices through the discovery and preclinical phases of development. The company operates through two segments: Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through DSA segment, it supports the discovery, nonclinical development and clinical development needs of researchers and clinicians for primarily small molecule drug candidates, as well as biotherapeutics and biomedical devices. Through RMS segment, it offers access to a range of small and large research models for basic research and drug discovery and development, as well as specialized models for specific diseases and therapeutic areas.
Company Info
INOTIV INC
2701 Kent Ave
West Lafayette INDIANA 47906 US
CEO: Robert W. Leasure Jr.
Employees: 1945
Phone: 13174634527
INOTIV INC / NOTV FAQ
Can you describe the business of INOTIV INC?
Inotiv, Inc. is a pharmaceutical development company, which engages in the provision of nonclinical and analytical drug discovery and development services primarily to the pharmaceutical and medical device industries and selling a range of research-quality animals and diets to academia and government clients. The company is headquartered in West Lafayette, Indiana and currently employs 1,945 full-time employees. Its products and services focus on bringing new drugs and medical devices through the discovery and preclinical phases of development. The company operates through two segments: Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through DSA segment, it supports the discovery, nonclinical development and clinical development needs of researchers and clinicians for primarily small molecule drug candidates, as well as biotherapeutics and biomedical devices. Through RMS segment, it offers access to a range of small and large research models for basic research and drug discovery and development, as well as specialized models for specific diseases and therapeutic areas.
What is the current price of NOTV stock?
The current stock price of NOTV is 0.6074 USD. The price decreased by -3.77% in the last trading session.
Does NOTV stock pay dividends?
NOTV does not pay a dividend.
How is the ChartMill rating for INOTIV INC?
NOTV has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Is INOTIV INC (NOTV) stock a good buy?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on NOTV.
Who owns INOTIV INC?
You can find the ownership structure of INOTIV INC (NOTV) on the Ownership tab.
What is the outstanding short interest for INOTIV INC?
The outstanding short interest for INOTIV INC (NOTV) is 7.37% of its float.
NOTV Technical Analysis
NOTV Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to NOTV. NOTV has a bad profitability rating. Also its financial health evaluation is rather negative.
NOTV Financial Highlights
Over the last trailing twelve months NOTV reported a non-GAAP Earnings per Share(EPS) of -2.22. The EPS increased by 47.02% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -8.9% | ||
| ROE | -50.45% | ||
| Debt/Equity | 0.04 |
NOTV Forecast & Estimates
9 analysts have analysed NOTV and the average price target is 4.93 USD. This implies a price increase of 711.65% is expected in the next year compared to the current price of 0.6074.
For the next year, analysts expect an EPS growth of 8.11% and a revenue growth 4.92% for NOTV